Back to top
Rydex Series Fds, Biotechnology Fund H Class: (MF: RYOAX)
(NASDAQ Mutual Funds) As of Nov 14, 2025 05:45 PM ET
$65.35 USD
+0.23 (0.35%)
Zacks MF Rank
3-Hold of 5 3
Latest Performance as of Oct 31, 2025
| Total Return %* | Percentile Rank Objective | |
|---|---|---|
| YTD | 23.22 | 14 |
| 3 months | 20.31 | 20 |
| 6 months | 24.59 | 16 |
| 1 Year | 14.90 | 10 |
| 3 Year | 9.54 | 34 |
| 5 Year | 5.31 | 67 |
| 10 Year | 5.36 | 92 |
* Annual for three years and beyond.
| Bull Market (9/02 - 10/07) | 88.68 |
| Bear Market (10/07 - 2/09) | -26.94 |
| Bull Market (2/09 - 3/21) | 698.95 |
Load Adjusted Returns as of Oct 31, 2025
| 1 Year | 4.05 |
| 5 Year | 2.98 |
| 10 Year | 5.11 |
| Since Inception | 9.83 |
Quarterly Return
| 1st Qtr. | 2nd Qtr. | 3rd Qtr. | 4th Qtr. | |
|---|---|---|---|---|
| 2025 | -1.41 | -0.17 | 15.06 | NA |
| 2024 | 0.73 | 2.02 | 4.84 | -8.10 |
| 2023 | -2.24 | 0.03 | -3.90 | 12.58 |
| 2022 | -9.93 | -10.29 | -2.20 | 9.76 |
| 2021 | -1.60 | 10.00 | -3.24 | -3.02 |
| 2020 | -14.68 | 28.19 | 0.41 | 10.88 |
Annual Return
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| % Total Return | 23.22 | -0.98 | 5.80 | -13.27 | 1.56 | 21.78 | 24.69 | -9.21 | 29.43 | -19.72 | 8.39 |
| % Total Return Rel to Index | 6.01 | -26.00 | -20.44 | 4.92 | -27.12 | 3.37 | -6.79 | -4.82 | 7.64 | -31.66 | 7.00 |
| % Total Return Rel to Peer | 10.49 | -3.60 | 0.03 | -3.86 | -7.12 | 0.50 | -1.98 | -9.34 | 7.31 | -8.94 | 0.96 |
| % Perf Quintile vs Peer* | 0.00 | 0.00 | 3.00 | 4.00 | 5.00 | 3.00 | 4.00 | 5.00 | 2.00 | 5.00 | 3.00 |
| % Dividends | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| % Yield | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Gains ($) | 0.00 | 9.42 | 0.00 | 0.90 | 15.77 | 6.95 | 3.60 | 9.88 | 4.70 | 0.00 | 1.28 |
| Expense Ratio | 1.64 | 1.65 | 1.64 | 1.61 | 1.72 | 1.73 | 1.71 | 1.62 | 1.61 | 1.65 | 1.83 |
* 1 = Top 20%, 5 = Bottom 20%